elosulfase alfa (vimizim) Report issue

Biologics Recombinant protein Orphan Drug FDA Approved FDA First in Class Fast Track FDA
AACT ChEMBL DrugBank Drug Central Drugs@FDA KEGG MeSH repoDB
Back

Drug Pricing Summary

VA Big4

$875.1100

VA FSS

$1156.6400

Drug Product Pricing

Product $/unit Ctry. List Type
Product (units) Manufacturer
elosulfase alfa 5 mg / 5 mL (5 mL INJECTION) $875.1100 VA Big4
  • VIMIZIM (1)
    		•  BioMarin Pharmaceutical, Inc.
    elosulfase alfa 5 mg / 5 mL (5 mL INJECTION) $1156.6400 VA FSS
  • VIMIZIM (1)
    		•  BioMarin Pharmaceutical, Inc.

    Note: This drug pricing data is preliminary, incomplete, and may contain errors.

    Feedback

    Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

    Report issue